Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated Umbilical Cord Blood Microtransplantation in AML
NCT06105658Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of unrelated umbilical cord blood in acute myeloid leukemia (AML), sponsored by The First Affiliated Hospital of USTC. Started Oct 2023; status: recruiting.
02
Drugs
unrelated umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT06105658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06105658.